Latest Press Releases
View all
TimeHeadline
15m agoCanadian Gold Resources Strengthens Board with Capital Markets Veteran Kenneth Chernin
15m agoWaraba Gold Signs Binding Agreement to Establish Joint Venture Relating to Tengrela South Exploration Permit Application in Cote d'Ivoire
15m agoSierra Madre Announces Shareholder Approval of Acquisition of Del Toro Silver Mine
15m agoFirst Quantum Minerals Reports First Quarter 2026 Results
15m agoDistrict Metals Announces $10 Million Private Placement Financing
Vyne Therapeutics Inc logo

Vyne Therapeutics Inc

About

Vyne Therapeutics Inc (NASDAQ:VYNE) — investor relations, events, news, and company updates on 6ix.

Latest News

Dec 17 2025
VYNE Therapeutics and Yarrow Bioscience Announce Merger Agreement
Dec 17 2025
VYNE Therapeutics and Yarrow Bioscience Announce Merger Agreement 
Nov 6 2025
VYNE Therapeutics Reports 2025 Third Quarter Financial Results and Provides Business Update
Aug 14 2025
VYNE Therapeutics Reports 2025 Second Quarter Financial Results and Provides Business Update
Jul 30 2025
VYNE Therapeutics Announces Topline Results from Phase 2b Trial with Repibresib Gel in Nonsegmental Vitiligo

Financials

Revenue
$570 K
Market Cap
$20.12 M
EPS
-0.63

Community Chat

Ask AI

6ix6ixAIEvents